Cellular accumulation of antineoplaston AS21 in human hepatoma cells
- 6 January 1995
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 88 (1) , 107-112
- https://doi.org/10.1016/0304-3835(94)03621-o
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Butyrate as a differentiating agent: pharmacokinetics, analogues and current statusCancer Letters, 1994
- Effects of Phenylacetate on Cells from Patients with B-Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1994
- Differentiation Therapy of LeukemiaLeukemia & Lymphoma, 1994
- HepG2 Cells: An in Vitro Model for P450-Dependent Metabolism of AcetaminophenBiochemical and Biophysical Research Communications, 1993
- Induction of erythroid differentiation and fetal hemoglobin production in human leukemic cells treated with phenylacetateBlood, 1992
- Metabolic basis for differential glutamine requirements of human leukemia cell linesJournal of Cellular Physiology, 1990
- Waste Nitrogen Excretion Via Amino Acid Acylation: Benzoate and Phenylacetate in Lysinuric Protein IntolerancePediatric Research, 1986
- Antineoplaston A 10Drugs of the Future, 1985
- Glutamine Transport Across Biological MembranesPublished by Springer Nature ,1984
- Phenylacetic acid in human body fluids: high correlation between plasma and cerebrospinal fluid concentration values.Journal of Neurology, Neurosurgery & Psychiatry, 1982